Update your Find a Dermatologist profile, the Academy's directory that's visited by over 1 million people a year.
Learn about the Academy's efforts to refocus its brand on education, advocacy, member-centricity, and innovation.
Stream over 75 sessions covering the full breadth of dermatology and connect with other attendees virtually. Registration is open!
Discover the wealth of educational opportunities offered through the Academy.
Find practical guidance on coding issues common in dermatology practices.
Learn how to avoid a penalty and earn an incentive when reporting MIPS.
Review current clinical guidelines, those in development, and guidelines that the AAD has collaborated on.
The Academy has developed 22 quality measures to help advance quality improvement.
Read this month's top stories in Dermatology World.
Check out DermWorld Insights & Inquiries for the latest updates from Dr. Warren Heymann
Access tools and practical guidance in evaluating and overcoming personal and staff burnout.
Get help to evaluate what practice model fits your needs, as well as guidance on selling a practice.
Learn about the Academy's advocacy priorities and how to join efforts to protect your practice.
Access resources to help you promote the specialty in your community and beyond.
ROSEMONT, Ill. (Nov. 5, 2019) — One-third of psoriasis cases begin in the pediatric years, and onset is most common during adolescence for the chronic, multisystem, inflammatory skin disease that causes the skin to develop new skin cells too rapidly. That’s why the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) are releasing guidelines to help ensure that pediatric psoriasis patients receive the best possible treatment and care.
The joint AAD/NPF ‘Guidelines of Care for the Management and Treatment of Psoriasis in Pediatric Patients,’ published today in the Journal of the American Academy of Dermatology, outline best practices for treatment of the disease in this vulnerable population. Developed by board-certified dermatologists, the guidelines are based on the most up-to-date scientific evidence for managing the disease.
“Compared to adults, pediatric psoriasis patients have a unique physiology, drug tolerance and patient/caregiver/physician interaction dynamic that can make it more challenging to manage,” said board-certified dermatologist Alan Menter, MD, FAAD, co-chair of the AAD’s Psoriasis Guideline Workgroup. “Our goal with the guidelines was to compile the latest research and provide recommendations to help secure the best course of care for this young population, which has to deal with not only skin issues, but also the psychological aspects so common in the pediatric group.”
Because psoriasis can increase a person’s risk of developing certain diseases, like diabetes, the new guidelines address some of those comorbidities in young people:
The link between obesity and psoriasis is greater for children than adults.
There may be a link between type 1 diabetes and psoriasis, as insulin resistance in children with psoriasis is estimated to be approximately twice that of children without the condition.
Inflammatory bowel disease is three to four times more common in pediatric psoriasis patients than in kids who don’t have psoriasis.
Unlike adult psoriasis patients there’s not enough evidence to support a relationship between psoriasis and heart disease in young patients, though experts recommend that children with psoriasis undergo appropriate cardiovascular screening, regardless.
In general, psoriasis can be exacerbated by multiple factors, including infections, stressors and skin trauma. “Specifically in the young population, psoriasis flare-ups can be associated with emotional stress, increased body mass index, second-hand cigarette smoke, strep infection and corticosteroid withdrawal,” said board-certified dermatologist and AAD Psoriasis Guideline Workgroup co-chair Craig Elmets, MD, FAAD.
That emotional stress can also manifest psychosocially in children with visible skin disease. Dr. Menter points out that kids with psoriasis are susceptible to bullying, name-calling and shaming at school and in other social settings.
“We’ve found that pediatric psoriasis patients have higher rates of depression and anxiety than their peers and use psychiatric medications more frequently,” he said. “Those are all addressed in these guidelines in the hopes that more people will recognize the seriousness of this disease in young people.”
Also outlined in the guidelines are the physical symptoms of the disease, which can include pain and itchiness along with stinging, burning and tightening sensations. Itch is highlighted as an under-recognized, serious symptom that plagues pediatric psoriasis patients and aggravates and spreads the psoriasis lesions. As president and CEO of the National Psoriasis Foundation Randy Beranek notes, these burdens take a heavy toll on children with the disease.
“The physical and emotional impact of psoriasis is tremendous, especially for our most vulnerable population: children. Treating pediatric patients with guidelines based on the most recent scientific information gives health care providers the best chance at finding the most successful course of treatment that enables children to live a healthy life,” said Beranek.
There’s no cure for psoriasis; however, getting treatment from a board-certified dermatologist and making lifestyle changes can help control the condition. Dr. Elmets recommends these tips to help manage psoriasis:
Identify (and avoid) the patients’ triggers
Stick to a good psoriasis skin care routine
Live a healthy lifestyle
Use appropriate medications as needed
“Psoriasis is a life-long condition, so as dermatologists, it’s imperative to empower and educate patients, caregivers and primary care providers regarding this disease,” said board-certified dermatologist George J. Hruza, MD, MBA, FAAD, president of the AAD. “These guidelines were created to help optimize patient care outcomes, ensure patient satisfaction and afford pediatric psoriasis patients a better quality of life.”
To find a board-certified dermatologist in your area, visit aad.org/findaderm.
# # #
Nicole Dobkin, (847) 240-1746, email@example.com
Cristina Mutchler, (847) 240-1714, firstname.lastname@example.org
Psoriasis Resource Center
What’s the Difference Between Eczema and Psoriasis?
About the AAD
Headquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 20,000 physicians worldwide, the AAD is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the AAD at (888) 462-DERM (3376) or aad.org. Follow the AAD on Facebook (American Academy of Dermatology), Twitter (@AADskin), Instagram (@AADskin1), or YouTube (AcademyofDermatology).
The Journal of the American Academy of Dermatology (JAAD) is the most widely read dermatology journal in the world, according to Kantar Media. JAAD’s 2018 Impact Factor is 7.102, according to the Clarivate Analytics Journal Impact Factor report. JAAD is the second most-cited dermatology journal. Follow @JAADJournals on Facebook, Twitter and Instagram.
About the National Psoriasis Foundation
Serving its community through more than 50 years of patient support, advocacy, research funding, and education, the National Psoriasis Foundation (NPF) is the world’s leading nonprofit fighting for individuals with psoriasis and psoriatic arthritis. The NPF mission is to drive efforts to cure psoriatic disease and dramatically improve the lives of more than 8 million Americans affected by this chronic immune-mediated disease. As part of that effort, NPF created its Patient Navigation Center to offer personalized assistance to everyone with psoriasis or psoriatic arthritis. To date, NPF has funded more than $21 million in research grants and fellowships that help drive discoveries that may lead to more and better treatments and ultimately a cure. Learn more at www.psoriasis.org